HypoSafe A/S is pioneering cognitive technologies designed to help and empower people. We create tiny implants that monitor brain activity to convey relevant information and issue alerts. Our devices can be used for medical or therapeutic purposes or for enhancement. We are currently clinically testing the world’s first 24/7 on-line EEG monitoring device dedicated for diabetics unable to feel and respond to a critical low blood sugar level. By warning the carrier before a critically low blood sugar level is reached the device prevents hypoglycemia with potential fatal consequences. HypoSafe A/S is continually exploring new applications of our core technology. We will proudly announce when we have news to break about additional avenues.
Looking for a particular HypoSafe A/S employee's phone or email?
The HypoSafe A/S annual revenue was $3.6 million in 2026.
HypoSafe A/S is based in Kongens Lyngby, Capital Region.
The SIC codes for HypoSafe A/S are [38, 384].